Copyright 2016 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
Most women with ovarian cancer present at an advanced stage, when the case-fatality rate is high. Approximately 22 280 women are diagnosed with ovarian cancer in the United States each year; 60% are classified as advanced stage, and the overall 5-year survival for these women is 28%.1 Reliable approaches for early detection of ovarian cancer have thus far been difficult to establish. The recently released report from the Institute of Medicine of the National Academies of Sciences, Engineering, and Medicine Committee on the State of the Science in Ovarian Cancer Research, titled Ovarian Cancers: Evolving Paradigms in Research and Care,2 highlights key gaps in the evidence base of ovarian cancer research and underscores opportunities that could affect many women. This congressionally mandated report, sponsored by the Centers for Disease Control and Prevention, has its origins in the Gynecologic Cancer Education and Awareness Act—more commonly known as Johanna’s Law, named for Johanna Silver Gordon, a schoolteacher who died of ovarian cancer.
Levine DA, Karlan BY, Strauss JF. Evolving Approaches in Research and Care for Ovarian CancersA Report From the National Academies of Sciences, Engineering, and Medicine. JAMA. 2016;315(18):1943–1944. doi:10.1001/jama.2016.2640
Customize your JAMA Network experience by selecting one or more topics from the list below.